Download PDF
Hamostaseologie 2023; 43(05): 338-347
DOI: 10.1055/a-2113-1134
Review Article

Flow Chamber Analyses in Cardiovascular Research: Impact of Platelets and the Intercellular Crosstalk with Endothelial Cells, Leukocytes, and Red Blood Cells

Kim Jürgen Krott
1   Department of Vascular- and Endovascular Surgery, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany
,
Tobias Feige
1   Department of Vascular- and Endovascular Surgery, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany
,
Margitta Elvers
1   Department of Vascular- and Endovascular Surgery, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany
› Author Affiliations Funding The study was supported by the Deutsche Forschungsgemeinschaft (DFG), grant number EL651/6-1; EL651/8-1 and Collaborative Research Centre TRR259 (Aortic Disease—grant no. 397484323) to M.E.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Platelets are main drivers of thrombus formation. Besides platelet aggregate formation, platelets interact with different blood cells such as red blood and white blood cells (RBCs, WBCs) and endothelial cells (ECs), to promote thrombus formation and inflammation. In the past, the role of different proteins in platelet adhesion, activation, and aggregate formation has been analyzed using platelets/mice with a genetic loss of a certain protein. These knock-out mouse models have been investigated for changes in experimental arterial thrombosis or hemostasis. In this review, we focused on the Maastricht flow chamber, which is a very elegant tool to analyze thrombus formation under flow using whole blood or different blood cell components of genetically modified mice. Besides, the interaction of platelets with RBCs, WBCs, and ECs under flow conditions has been evaluated with regard to thrombus formation and platelet-mediated inflammation. Importantly, alterations in thrombus formation as emerged in the flow chamber frequently reflect arterial thrombosis in different mouse models. Thus, the results of flow chamber experiments in vitro are excellent indicators for differences in arterial thrombosis in vivo. Taken together, the Maastricht flow chamber can be used to (1) determine the severity of platelet alterations in different knock-out mice; (2) analyze differences in platelet adhesion, aggregation, and activation; (3) investigate collagen and non–collagen-dependent alterations of thrombus formation; and (4) highlight differences in the interaction of platelets with different blood/ECs. Thus, this experimental approach is a useful tool to increase our understanding of signaling mechanisms that drive arterial thrombosis and hemostasis.

Keywords

arterial thrombus formation - collagen - glycoprotein VI - platelets - flow chamber


Publication History

Received: 02 May 2023

Accepted: 16 June 2023

Article published online:
19 October 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Nagy M, van Geffen JP, Stegner D. et al. Comparative analysis of microfluidics thrombus formation in multiple genetically modified mice: link to thrombosis and hemostasis. Front Cardiovasc Med 2019; 6: 99
    CrossrefPubMedGoogle Scholar
  • 2 Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res 2007; 100 (12) 1673-1685
    CrossrefPubMedGoogle Scholar
  • 3 Stegner D, Nieswandt B. Platelet receptor signaling in thrombus formation. J Mol Med (Berl) 2011; 89 (02) 109-121
    CrossrefPubMedGoogle Scholar
  • 4 van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol 2019; 16 (03) 166-179
    CrossrefPubMedGoogle Scholar
  • 5 Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev 2013; 93 (01) 327-358
    CrossrefPubMedGoogle Scholar
  • 6 Auger JM, Kuijpers MJ, Senis YA, Watson SP, Heemskerk JW. Adhesion of human and mouse platelets to collagen under shear: a unifying model. FASEB J 2005; 19 (07) 825-827
    CrossrefPubMedGoogle Scholar
  • 7 Nieswandt B, Brakebusch C, Bergmeier W. et al. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J 2001; 20 (09) 2120-2130
    CrossrefPubMedGoogle Scholar
  • 8 Nieswandt B, Varga-Szabo D, Elvers M. Integrins in platelet activation. J Thromb Haemost 2009; 7 (Suppl. 01) 206-209
    CrossrefPubMedGoogle Scholar
  • 9 Siljander PR, Munnix IC, Smethurst PA. et al. Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood 2004; 103 (04) 1333-1341
    CrossrefPubMedGoogle Scholar
  • 10 Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 2008; 28 (03) 403-412
    CrossrefPubMedGoogle Scholar
  • 11 Bigalke B, Elvers M, Schönberger T, Gawaz M. Platelet and soluble glycoprotein VI - novel applications in diagnosis and therapy. Curr Drug Targets 2011; 12 (12) 1821-1830
    CrossrefPubMedGoogle Scholar
  • 12 Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor?. Blood 2003; 102 (02) 449-461
    CrossrefPubMedGoogle Scholar
  • 13 Elvers M, Herrmann A, Seizer P. et al. Intracellular cyclophilin A is an important Ca(2+) regulator in platelets and critically involved in arterial thrombus formation. Blood 2012; 120 (06) 1317-1326
    CrossrefPubMedGoogle Scholar
  • 14 Mammadova-Bach E, Nagy M, Heemskerk JWM, Nieswandt B, Braun A. Store-operated calcium entry in thrombosis and thrombo-inflammation. Cell Calcium 2019; 77: 39-48
    CrossrefPubMedGoogle Scholar
  • 15 Senis YA, Mazharian A, Mori J. Src family kinases: at the forefront of platelet activation. Blood 2014; 124 (13) 2013-2024
    CrossrefPubMedGoogle Scholar
  • 16 Guidetti GF, Canobbio I, Torti M. PI3K/Akt in platelet integrin signaling and implications in thrombosis. Adv Biol Regul 2015; 59: 36-52
    CrossrefPubMedGoogle Scholar
  • 17 Harper MT, Poole AW. Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation. J Thromb Haemost 2010; 8 (03) 454-462
    CrossrefPubMedGoogle Scholar
  • 18 Pleines I, Eckly A, Elvers M. et al. Multiple alterations of platelet functions dominated by increased secretion in mice lacking Cdc42 in platelets. Blood 2010; 115 (16) 3364-3373
    CrossrefPubMedGoogle Scholar
  • 19 Pleines I, Elvers M, Strehl A. et al. Rac1 is essential for phospholipase C-gamma2 activation in platelets. Pflugers Arch 2009; 457 (05) 1173-1185
    CrossrefPubMedGoogle Scholar
  • 20 Pleines I, Hagedorn I, Gupta S. et al. Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis. Blood 2012; 119 (04) 1054-1063
    CrossrefPubMedGoogle Scholar
  • 21 Elvers M, Stegner D, Hagedorn I. et al. Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. Sci Signal 2010; 3 (103) ra1
    CrossrefPubMedGoogle Scholar
  • 22 Metz LM, Elvers M. Pannexin-1 activation by phosphorylation is crucial for platelet aggregation and thrombus formation. Int J Mol Sci 2022; 23 (09) 5059
    CrossrefPubMedGoogle Scholar
  • 23 Hoermann H, Krueger I, Maurus N. et al. The proteoglycan biglycan modulates platelet adhesion and thrombus formation in a GPVI-dependent manner. Int J Mol Sci 2021; 22 (22) 12168
    CrossrefPubMedGoogle Scholar
  • 24 Gowert NS, Krüger I, Klier M. et al. Loss of reelin protects mice against arterial thrombosis by impairing integrin activation and thrombus formation under high shear conditions. Cell Signal 2017; 40: 210-221
    CrossrefPubMedGoogle Scholar
  • 25 Krueger I, Gremer L, Mangels L. et al. Reelin amplifies glycoprotein VI activation and alphaIIb beta3 integrin outside-in signaling via PLC gamma 2 and rho GTPases. Arterioscler Thromb Vasc Biol 2020; 40 (10) 2391-2403
    CrossrefPubMedGoogle Scholar
  • 26 Agbani EO, Poole AW. Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis. Blood 2017; 130 (20) 2171-2179
    CrossrefPubMedGoogle Scholar
  • 27 Klatt C, Krüger I, Zey S. et al. Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis. J Clin Invest 2018; 128 (09) 3906-3925
    CrossrefPubMedGoogle Scholar
  • 28 Baaten CCFMJ, Meacham S, de Witt SM. et al. A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding. Blood 2018; 132 (24) e35-e46
    CrossrefPubMedGoogle Scholar
  • 29 Nieswandt B, Schulte V, Bergmeier W. et al. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med 2001; 193 (04) 459-469
    CrossrefPubMedGoogle Scholar
  • 30 Navarro S, Starke A, Heemskerk JWM, Kuijpers MJE, Stegner D, Nieswandt B. Targeting of a conserved epitope in mouse and human GPVI differently affects receptor function. Int J Mol Sci 2022; 23 (15) 8610
    CrossrefPubMedGoogle Scholar
  • 31 Kato K, Kanaji T, Russell S. et al. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 2003; 102 (05) 1701-1707
    CrossrefPubMedGoogle Scholar
  • 32 Navarro S, Stegner D, Nieswandt B, Heemskerk JWM, Kuijpers MJE. Temporal roles of platelet and coagulation pathways in collagen- and tissue factor-induced thrombus formation. Int J Mol Sci 2022; 23 (01) 358
    CrossrefPubMedGoogle Scholar
  • 33 Elvers M, Pozgaj R, Pleines I. et al. Platelet hyperreactivity and a prothrombotic phenotype in mice with a gain-of-function mutation in phospholipase Cgamma2. J Thromb Haemost 2010; 8 (06) 1353-1363
    CrossrefPubMedGoogle Scholar
  • 34 May F, Hagedorn I, Pleines I. et al. CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. Blood 2009; 114 (16) 3464-3472
    CrossrefPubMedGoogle Scholar
  • 35 Bourne JH, Smith CW, Jooss NJ. et al. CLEC-2 supports platelet aggregation in mouse but not human blood at arterial shear. Thromb Haemost 2022; 122 (12) 1988-2000
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Suzuki-Inoue K, Inoue O, Ding G. et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem 2010; 285 (32) 24494-24507
    CrossrefPubMedGoogle Scholar
  • 37 Bender M, May F, Lorenz V. et al. Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice. Arterioscler Thromb Vasc Biol 2013; 33 (05) 926-934
    CrossrefPubMedGoogle Scholar
  • 38 Thielmann I, Stegner D, Kraft P. et al. Redundant functions of phospholipases D1 and D2 in platelet α-granule release. J Thromb Haemost 2012; 10 (11) 2361-2372
    CrossrefPubMedGoogle Scholar
  • 39 Borst O, Schmidt EM, Münzer P. et al. The serum- and glucocorticoid-inducible kinase 1 (SGK1) influences platelet calcium signaling and function by regulation of Orai1 expression in megakaryocytes. Blood 2012; 119 (01) 251-261
    CrossrefPubMedGoogle Scholar
  • 40 Varga-Szabo D, Braun A, Kleinschnitz C. et al. The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction. J Exp Med 2008; 205 (07) 1583-1591
    CrossrefPubMedGoogle Scholar
  • 41 Münzer P, Borst O, Walker B. et al. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation. Arterioscler Thromb Vasc Biol 2014; 34 (01) 61-71
    CrossrefPubMedGoogle Scholar
  • 42 Elvers M. RhoGAPs and rho GTPases in platelets. Hamostaseologie 2016; 36 (03) 168-177
    Article in Thieme ConnectPubMedGoogle Scholar
  • 43 Fotinos A, Klier M, Gowert NS. et al. Loss of oligophrenin1 leads to uncontrolled Rho activation and increased thrombus formation in mice. J Thromb Haemost 2015; 13 (04) 619-630
    CrossrefPubMedGoogle Scholar
  • 44 Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc Res 1973; 5 (02) 167-179
    CrossrefPubMedGoogle Scholar
  • 45 Savage B, Saldívar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84 (02) 289-297
    CrossrefPubMedGoogle Scholar
  • 46 Estevez B, Shen B, Du X. Targeting integrin and integrin signaling in treating thrombosis. Arterioscler Thromb Vasc Biol 2015; 35 (01) 24-29
    CrossrefPubMedGoogle Scholar
  • 47 Jurk K, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost 2005; 31 (04) 381-392
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8 (11) 1227-1234
    CrossrefPubMedGoogle Scholar
  • 49 Heemskerk JW, Sakariassen KS, Zwaginga JJ, Brass LF, Jackson SP, Farndale RW. Biorheology Subcommittee of the SSC of the ISTH. Collagen surfaces to measure thrombus formation under flow: possibilities for standardization. J Thromb Haemost 2011; 9 (04) 856-858
    CrossrefPubMedGoogle Scholar
  • 50 Cosemans JM, Kuijpers MJ, Lecut C. et al. Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions. Atherosclerosis 2005; 181 (01) 19-27
    CrossrefPubMedGoogle Scholar
  • 51 Munnix IC, Kuijpers MJ, Auger J. et al. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arterioscler Thromb Vasc Biol 2007; 27 (11) 2484-2490
    CrossrefPubMedGoogle Scholar
  • 52 Cosemans JMEM, Iserbyt BF, Deckmyn H, Heemskerk JWM. Multiple ways to switch platelet integrins on and off. J Thromb Haemost 2008; 6 (08) 1253-1261
    CrossrefPubMedGoogle Scholar
  • 53 Jackson SP. The growing complexity of platelet aggregation. Blood 2007; 109 (12) 5087-5095
    CrossrefPubMedGoogle Scholar
  • 54 Whelihan MF, Mann KG. The role of the red cell membrane in thrombin generation. Thromb Res 2013; 131 (05) 377-382
    CrossrefPubMedGoogle Scholar
  • 55 Walker B, Towhid ST, Schmid E. et al. Dynamic adhesion of eryptotic erythrocytes to immobilized platelets via platelet phosphatidylserine receptors. Am J Physiol Cell Physiol 2014; 306 (03) C291-C297
    CrossrefPubMedGoogle Scholar
  • 56 Gersh KC, Nagaswami C, Weisel JW. Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes. Thromb Haemost 2009; 102 (06) 1169-1175
    Article in Thieme ConnectPubMedGoogle Scholar
  • 57 Wohner N, Sótonyi P, Machovich R. et al. Lytic resistance of fibrin containing red blood cells. Arterioscler Thromb Vasc Biol 2011; 31 (10) 2306-2313
    CrossrefPubMedGoogle Scholar
  • 58 Wohner N. Role of cellular elements in thrombus formation and dissolution. Cardiovasc Hematol Agents Med Chem 2008; 6 (03) 224-228
    CrossrefPubMedGoogle Scholar
  • 59 Machovich R, Owen WG. The elastase-mediated pathway of fibrinolysis. Blood Coagul Fibrinolysis 1990; 1 (01) 79-90
    CrossrefPubMedGoogle Scholar
  • 60 Kolev K, Machovich R. Molecular and cellular modulation of fibrinolysis. Thromb Haemost 2003; 89 (04) 610-621
    Article in Thieme ConnectPubMedGoogle Scholar
  • 61 Berger G, Hartwell DW, Wagner DD. P-selectin and platelet clearance. Blood 1998; 92 (11) 4446-4452
    CrossrefPubMedGoogle Scholar
  • 62 André P, Hartwell D, Hrachovinová I, Saffaripour S, Wagner DD. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A 2000; 97 (25) 13835-13840
    CrossrefPubMedGoogle Scholar
  • 63 Massberg S, Grahl L, von Bruehl ML. et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010; 16 (08) 887-896
    CrossrefPubMedGoogle Scholar
  • 64 Fuchs TA, Brill A, Duerschmied D. et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 2010; 107 (36) 15880-15885
    CrossrefPubMedGoogle Scholar
  • 65 Fuchs TA, Brill A, Wagner DD. Neutrophil extracellular trap (NET) impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol 2012; 32 (08) 1777-1783
    CrossrefPubMedGoogle Scholar
  • 66 Sorvillo N, Cherpokova D, Martinod K, Wagner DD. Extracellular DNA NET-works with dire consequences for health. Circ Res 2019; 125 (04) 470-488
    CrossrefPubMedGoogle Scholar
  • 67 Kulkarni S, Woollard KJ, Thomas S, Oxley D, Jackson SP. Conversion of platelets from a proaggregatory to a proinflammatory adhesive phenotype: role of PAF in spatially regulating neutrophil adhesion and spreading. Blood 2007; 110 (06) 1879-1886
    CrossrefPubMedGoogle Scholar
  • 68 Morozova DS, Martyanov AA, Obydennyi SI. et al. Ex vivo observation of granulocyte activity during thrombus formation. BMC Biol 2022; 20 (01) 32
    CrossrefPubMedGoogle Scholar
  • 69 Goel MS, Diamond SL. Adhesion of normal erythrocytes at depressed venous shear rates to activated neutrophils, activated platelets, and fibrin polymerized from plasma. Blood 2002; 100 (10) 3797-3803
    CrossrefPubMedGoogle Scholar
  • 70 Noh J-Y, Lim KM, Bae ON. et al. Procoagulant and prothrombotic activation of human erythrocytes by phosphatidic acid. Am J Physiol Heart Circ Physiol 2010; 299 (02) H347-H355
    CrossrefPubMedGoogle Scholar
  • 71 Hermand P, Gane P, Huet M. et al. Red cell ICAM-4 is a novel ligand for platelet-activated alpha IIbbeta 3 integrin. J Biol Chem 2003; 278 (07) 4892-4898
    CrossrefPubMedGoogle Scholar
  • 72 Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89 (04) 1121-1132
    CrossrefPubMedGoogle Scholar
  • 73 Reimers RC, Sutera SP, Joist JH. Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms. Blood 1984; 64 (06) 1200-1206
    CrossrefPubMedGoogle Scholar
  • 74 Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am J Physiol 1996; 271 (6, Pt 2): H2717-H2722
    PubMedGoogle Scholar
  • 75 Elzey BD, Tian J, Jensen RJ. et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 2003; 19 (01) 9-19
    CrossrefPubMedGoogle Scholar
  • 76 Semple JW, Italiano Jr JE, Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011; 11 (04) 264-274
    CrossrefPubMedGoogle Scholar
  • 77 Hu H, Varon D, Hjemdahl P, Savion N, Schulman S, Li N. Platelet-leukocyte aggregation under shear stress: differential involvement of selectins and integrins. Thromb Haemost 2003; 90 (04) 679-687
    Article in Thieme ConnectPubMedGoogle Scholar
  • 78 Yan SL, Russell J, Granger DN. Platelet activation and platelet-leukocyte aggregation elicited in experimental colitis are mediated by interleukin-6. Inflamm Bowel Dis 2014; 20 (02) 353-362
    CrossrefPubMedGoogle Scholar
  • 79 Gerdes N, Seijkens T, Lievens D. et al. Platelet CD40 exacerbates atherosclerosis by transcellular activation of endothelial cells and leukocytes. Arterioscler Thromb Vasc Biol 2016; 36 (03) 482-490
    CrossrefPubMedGoogle Scholar
  • 80 Haselmayer P, Grosse-Hovest L, von Landenberg P, Schild H, Radsak MP. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 2007; 110 (03) 1029-1035
    CrossrefPubMedGoogle Scholar
  • 81 Swystun LL, Liaw PC. The role of leukocytes in thrombosis. Blood 2016; 128 (06) 753-762
    CrossrefPubMedGoogle Scholar
  • 82 Klier M, Gowert NS, Jäckel S, Reinhardt C, Elvers M. Phospholipase D1 is a regulator of platelet-mediated inflammation. Cell Signal 2017; 38: 171-181
    CrossrefPubMedGoogle Scholar
  • 83 Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 1998; 187 (03) 329-339
    CrossrefPubMedGoogle Scholar
  • 84 Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115 (12) 3378-3384
    CrossrefPubMedGoogle Scholar
  • 85 Massberg S, Brand K, Grüner S. et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002; 196 (07) 887-896
    CrossrefPubMedGoogle Scholar
  • 86 Romo GM, Dong JF, Schade AJ. et al. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 1999; 190 (06) 803-814
    CrossrefPubMedGoogle Scholar
  • 87 Theilmeier G, Michiels C, Spaepen E. et al. Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood 2002; 99 (12) 4486-4493
    CrossrefPubMedGoogle Scholar
  • 88 Coenen DM, Mastenbroek TG, Cosemans JMEM. Platelet interaction with activated endothelium: mechanistic insights from microfluidics. Blood 2017; 130 (26) 2819-2828
    CrossrefPubMedGoogle Scholar
  • 89 Dardik R, Savion N, Kaufmann Y, Varon D. Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA. Br J Cancer 1998; 77 (12) 2069-2075
    CrossrefPubMedGoogle Scholar
  • 90 Gowert NS, Klier M, Reich M. et al. Defective platelet activation and bleeding complications upon cholestasis in mice. Cell Physiol Biochem 2017; 41 (06) 2133-2149
    CrossrefPubMedGoogle Scholar
  • 91 Reusswig F, Fazel Modares N, Brechtenkamp M. et al. Efficiently restored thrombopoietin production by Ashwell-Morell receptor and IL-6R induced janus kinase 2/signal transducer and activator of transcription signaling early after partial hepatectomy. Hepatology 2021; 74 (01) 411-427
    CrossrefPubMedGoogle Scholar
  • 92 Urbahn MA, Kaup SC, Reusswig F. et al. Phospholipase D1 regulation of TNF-alpha protects against responses to LPS. Sci Rep 2018; 8 (01) 10006
    CrossrefPubMedGoogle Scholar
  • 93 Li TR, Liu FQ. β-Amyloid promotes platelet activation and activated platelets act as bridge between risk factors and Alzheimer's disease. Mech Ageing Dev 2022; 207: 111725
    CrossrefPubMedGoogle Scholar
  • 94 Jarre A, Gowert NS, Donner L. et al. Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer's disease. Cell Signal 2014; 26 (09) 2040-2050
    CrossrefPubMedGoogle Scholar
  • 95 Canobbio I, Visconte C, Oliviero B. et al. Increased platelet adhesion and thrombus formation in a mouse model of Alzheimer's disease. Cell Signal 2016; 28 (12) 1863-1871
    CrossrefPubMedGoogle Scholar
  • 96 Donner L, Fälker K, Gremer L. et al. Platelets contribute to amyloid-β aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release. Sci Signal 2016; 9 (429) ra52
    CrossrefPubMedGoogle Scholar
  • 97 Donner L, Toska LM, Krüger I. et al. The collagen receptor glycoprotein VI promotes platelet-mediated aggregation of β-amyloid. Sci Signal 2020; 13 (643) eaba9872
    CrossrefPubMedGoogle Scholar
  • 98 Nicoll JA, Yamada M, Frackowiak J, Mazur-Kolecka B, Weller RO. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement. Neurobiol Aging 2004; 25 (05) 589-597 , discussion 603–604
    CrossrefPubMedGoogle Scholar
  • 99 Gowert NS, Donner L, Chatterjee M. et al. Blood platelets in the progression of Alzheimer's disease. PLoS One 2014; 9 (02) e90523
    CrossrefPubMedGoogle Scholar